NL-OMON46555
Completed
Not Applicable
Obtaining blood from healthy volunteers for assay validation on iron parameters. - HAVIP
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Radboud Universitair Medisch Centrum
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants need to be healthy volunteers between 18 and 55 years old. They should live in the Netherlands and preferably in the area of Nijmegen. People who are diagnosed with any iron disorder can not participate in this study. Examples of Iron disorders are anemia, β\-thalassaemia, hemochromatosis and IRIDA. Also people that use any sort of medication can not participate, however the use of contraceptive pills is allowed.
Exclusion Criteria
- •If deviant iron parameter values are found in samples of the healthy volunteers they will be excluded from the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Blood donation by healthy volunteers for experimental in-vitro researchBreed infectieus en immunologisch klinisch relevante onderwerpencytokine responses10004018NL-OMON38115niversitair Medisch Centrum Sint Radboud1,000
Completed
Not Applicable
Trial for collection of blood samples from healed Covid-19 patients - research and development of in-vitro diagnosticsSARS-CoV-2 infectionCovid-19U07.1COVID-19, virus identifiedDRKS00022406R-Biopharm AG50
Recruiting
Not Applicable
Blood donation for experimental in vitro researchInfecties en niet-overdraagbare aandoeningen en ziektenInfections and non communicable disorders and diseasesNL-OMON53200Radboud Universitair Medisch Centrum2,000
Recruiting
Not Applicable
Collection of blood samples for the evaluation of the analytical performance of two new in vitro test systems for tuberculosis diagnosticsA15-A19TuberculosisDRKS00027129R-Biopharm AG636
Recruiting
Not Applicable
Collection of blood samples for research and development of an IP-10 TB-CLIA-AssayA15-A19TuberculosisDRKS00030861R-Biopharm AG200